As our aim was to identify specific immune components of p53-GOF OPLs that allows their malignant progression even after treatment with anti-PD-1, we compared the immune profiles of 4NQO-induced p53-GOF papillomas with those of p53-LOF and p53-WT papillomas. The gene discussed is TP53; the disease is papilloma.